Trademark Overview
On Friday, May 24, 2024, a trademark application was filed for HBS with the United States Patent and Trademark Office. The USPTO has given the HBS trademark a serial number of 98567877. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, February 25, 2025. The HBS trademark is filed in the Pharmaceutical Products category with the following description:
Topical nutraceutical preparations, namely topical creams, lotions, ointments for cuts and bruises, dry skin, dermatitis, wrinkles, scarring, skin cancer; transdermal nutraceutical preparations, namely transdermal creams, lotions, ointments for mood disorders, depression, anxiety, psychosis, PTSD, nausea, vomiting, pain, multiple sclerosis, seizures, Parkinson's disease, Huntington's disease, autism spectrum disorder, cerebral palsy, high blood pressure, stroke, metabolic syndrome, cardiovascular disease, substance abuse, glioblastoma, sleep disorders, liver health, lung health cancer, prostate health, erectile dysfunction, muscle gain, weight loss, hormone balancing; and nutraceutical oral supplements containing mushroom, namely capsules, tablets for health longevity, anxiety, depression, mood disorders, focus, psychosis, PTSD, lung health, liver health, heart health, substance abuse, sleep disorders.
